Literature DB >> 20158584

Efficacy and safety of 1064-nm Q-switched Nd:YAG laser with low fluence for keloids and hypertrophic scars.

S B Cho1, J H Lee, S H Lee, S J Lee, D Bang, S H Oh.   

Abstract

BACKGROUND: Several treatment modalities using laser devices have been used for the treatment of keloids and hypertrophic scars with various therapeutic outcomes.
OBJECTIVE: The purpose of this study was to describe the efficacy and safety of 1064-nm Q-switched (QS) Nd:YAG laser with low fluence on keloids and hypertrophic scars.
METHODS: Keloids and hypertrophic scars located at 21 anatomic sites in 12 Korean patients (10 men and 2 women; mean age 23.8 years, range 21-33) were treated using 1064-nm QS Nd:YAG laser with low fluence at 1-2 week intervals. Treatment settings were 1.8-2.2 J/cm(2), 7-mm spot size and 5-6 passes with appropriate overlapping.
RESULTS: Follow-up data collected 3 months after the final treatment revealed decreases in the mean score for the following lesion characteristics: pigmentation from 1.8 to 1.2; vascularity from 1.4 to 1.0; pliability from 3.0 to 2.0 and height from 2.3 to 1.8. The modified Vancouver General Hospital Burn Scar Assessment score decreased from 8.6 to 5.9 (P < 0.0001). Observed side-effects were a mild prickling sensation during treatment, and mild post-treatment erythema, both of which resolved within few hours.
CONCLUSION: Our results demonstrate that QS Nd:YAG laser with low fluence may be used for the treatment of keloids and hypertrophic scars.

Entities:  

Mesh:

Year:  2010        PMID: 20158584     DOI: 10.1111/j.1468-3083.2010.03593.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  11 in total

Review 1.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

2.  High-resolution ultrasound for keloids and hypertrophic scar assessment.

Authors:  Asmaa Mohammed Elrefaie; Rehab Mohammed Salem; Mohamed H Faheem
Journal:  Lasers Med Sci       Date:  2019-06-25       Impact factor: 3.161

Review 3.  Laser therapy for treating hypertrophic and keloid scars.

Authors:  Rafael Leszczynski; Carolina Ap da Silva; Ana Carolina Pereira Nunes Pinto; Uliana Kuczynski; Edina Mk da Silva
Journal:  Cochrane Database Syst Rev       Date:  2022-09-26

Review 4.  Keloids: Current and emerging therapies.

Authors:  Nkemcho Ojeh; Ambadasu Bharatha; Uma Gaur; Andrew LeRoy Forde
Journal:  Scars Burn Heal       Date:  2020-08-10

5.  A comprehensive reconstruction strategy for moderate to severe faciocervical scar contractures.

Authors:  Jue Wang; Jiang Wu; Minghuo Xu; Quanwen Gao; Baoguo Chen; Fang Wang; Hao Niu; Huifeng Song
Journal:  Lasers Med Sci       Date:  2020-11-06       Impact factor: 3.161

Review 6.  Laser and light-based treatment of Keloids--a review.

Authors:  A D Mamalis; H Lev-Tov; D-H Nguyen; J R Jagdeo
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-08-27       Impact factor: 6.166

7.  1064-nm Q-switched fractional Nd:YAG laser is safe and effective for the treatment of post-surgical facial scars.

Authors:  Lehavit Akerman; Efrat Solomon-Cohen; Mati Rozenblat; Emmilia Hodak; Moshe Lapidoth; Assi Levi
Journal:  Lasers Med Sci       Date:  2020-08-26       Impact factor: 3.161

8.  A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris.

Authors:  Juhee Park; Beom Joon Kim; Myeung Nam Kim; Chang Kyun Lee
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

Review 9.  Efficacy of the Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Keloid and Hypertrophic Scars: A Systematic Review and Meta-analysis.

Authors:  Lingfeng Pan; Haiyan Qin; Caihong Li; Guang Zhang; Liehao Yang; Lianbo Zhang
Journal:  Aesthetic Plast Surg       Date:  2022-01-21       Impact factor: 2.708

10.  Management of keloids and hypertrophic scars: current and emerging options.

Authors:  Gerd G Gauglitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.